stockrowBioCryst Pharmaceuticals, Inc.
BCRX Healthcare Drug Manufacturers Specialty & Generic
BioCryst Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $874.8 million, up 94.1% from fiscal 2024.
- Revenue
- +13.1%
- EPS
- +150.0%
- Free cash flow
- −18.7%
- Total debt
- +15.2%
Quarter to September 2026, against a year earlier
Follow BCRX
Alert me
BioCryst Pharmaceuticals, Inc. (BCRX) Gross margin
BioCryst Pharmaceuticals, Inc.'s gross margin over the twelve months to 30 September 2026 was 97.9%, up 0.1 percentage points from fiscal 2025 (97.8%). Over the past ten years it has ranged from 91.3% (fiscal 2016) to 100.0% (fiscal 2018); the current reading is higher than 82% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 97.8% | 0.54 |
| FY2024 | 97.3% | (1.37) |
| FY2023 | 98.7% | 1.02 |
| FY2022 | 97.6% | 2.23 |
| FY2021 | 95.4% | 4.10 |
| FY2020 | 91.3% | (1.07) |
| FY2019 | 92.4% | (7.63) |
| FY2018 | 100.0% | 4.53 |
| FY2017 | 95.5% | 4.19 |
| FY2016 | 91.3% | (5.89) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 99.1% | 0.89 |
| Jun 2026 | 98.2% | 1.68 |
| Mar 2026 | 96.6% | (1.10) |
| Dec 2025 | 97.7% | (0.97) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. | 97.9% |
| XERS Xeris Biopharma Holdings, Inc. compare | 87.4% |
| ANIP ANI Pharmaceuticals, Inc. compare | 61.1% |
| TRLV Trulieve Cannabis Corp. compare | 60.6% |
| PBH Prestige Consumer Healthcare Inc. compare | 52.5% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 44.4% |
| ALVO Alvotech compare | 42.7% |
| PRGO Perrigo Company plc compare | 32.3% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on BCRX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement